Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

7 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for Supplemental Form - 2075318v3.0 - E6201 Cover Page for Supplemental Form

- 09.01.15 - 1 Formular, 4 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for Supplemental Form A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B0ADEE-BA19-4B20-E034-0003BA12F5E7

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for RECIST Forms - 2075205v3.0 - E6201 Cover Page for RECIST Forms

- 09.01.15 - 1 Formular, 4 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for RECIST Forms A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B164EC-ED7F-4A7F-E034-0003BA12F5E7

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for Adverse Event Form - 2075284v3.0 - E6201 Cover Page for Adverse Event Form

- 09.01.15 - 1 Formular, 4 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for Adverse Event Form A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B0ABAE-0BB9-4B1E-E034-0003BA12F5E7

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for Hematology/Chemistry Forms - 2075247v3.0 - E6201 Cover Page for Hematology/Chemistry Forms

- 09.01.15 - 1 Formular, 4 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for Hematology/Chemistry Forms A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B0A8C1-ED1A-4B19-E034-0003BA12F5E7

CALGB: SOLID TUMOR EVALUATION FORM [80303] NCT00088894

- 21.06.15 - 1 Formular, 5 Itemgruppen, 20 Datenelemente, 1 Sprache
Itemgruppen: Header, Patient demographics, TARGET LESION(S), NON-TARGET LESION(S), Footer module
CALGB: SOLID TUMOR EVALUATION FORM [80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D6012DD9-1E79-035F-E034-0003BA12F5E7

Nontarget Lesions Supplemental Form NCT00058149

- 03.06.15 - 1 Formular, 4 Itemgruppen, 20 Datenelemente, 1 Sprache
Itemgruppen: ECOG clinical trial administrative data, NONTARGET LESIONS:, Comments, CCRR MODULE
Nontarget Lesions Supplemental Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A65D5AC6-6244-4284-E034-0003BA0B1A09

Nontarget Lesions Supplemental Form NCT00057876

- 03.06.15 - 1 Formular, 4 Itemgruppen, 20 Datenelemente, 1 Sprache
Itemgruppen: ECOG clinical trial administrative data, NONTARGET LESIONS:, Comments, CCRR MODULE
Nontarget Lesions Supplemental Form NCT00057876 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6238F51-F0B5-3C1D-E034-0003BA0B1A09

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video